Sera Prognostics (SERA) Return on Capital Employed Growth (1y) (2022 - 2026)
Sera Prognostics (SERA) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 216.00 |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | -1,638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,638.00 |
| Mar 31, 2026 | 184.00 |
| Dec 31, 2025 | 2,665.00 |
| Sep 30, 2025 | 1,969.00 |
| Jun 30, 2025 | 1,618.00 |
| Mar 31, 2025 | 409.00 |
| Dec 31, 2024 | -1,351.00 |
| Sep 30, 2024 | -1,059.00 |
| Jun 30, 2024 | -545.00 |
| Mar 31, 2024 | -922.00 |
| Dec 31, 2023 | -1,306.00 |
| Sep 30, 2023 | -925.00 |
| Jun 30, 2023 | -1,352.00 |
| Mar 31, 2023 | -1,489.00 |
| Dec 31, 2022 | -2,031.00 |
| Sep 30, 2022 | -1,977.00 |